• VIDEO: Avicenna Alliance
    at the European Parliament

    At the invitation of the European Parliament, Avicenna Alliance's leaders supported by senior people from FDA, ANSYS, Medtronic, CIPLA, VPHi, EFGCP and RPP, have explained to delegations from Europe, USA, India and Japan the central role played by in silico healthcare to accelerate medical innovation.

    View the video!

Avicenna Alliance news

Dassault Systèmes signs Research Agreement with the FDA

Dassault Systèmes and the U.S. Food and Drug Administration have concluded a five-year extension of their collaboration on the 3DEXPERIENCE...

find out more ›

European Commission launches tender for studies on AI and E-Health

On 7 August, the European Commission launched a tender for two studies to survey and analyse progress on the digital transformation...

find out more ›

Commission launches call for proposals to develop AI Excellence Centres

On 12 July, the European Commission has launched a call for proposals to develop a European network of artificial intelligence...

find out more ›

Show all activites

Avicenna Alliance the Association for Predictive Medicine

The Avicenna Alliance, is an association of industry and renowned academia/healthcare organizations who have a commercial or research interest in the development of in silico medicine. The Association, established in 2015, has its origins in the Virtual Physiological Human Initiative, a European Commission endorsed research area on computer modeling and simulation. Tasked by the European Commission with developing a “Roadmap for in silico medicine”, the Association now seeks to put this roadmap into policy and ensure the development of a regulated in silico market.

This Association bridges the gap between the scientific community, industry and policy makers by advocating for policy changes that take into account scientific and market developments.

read more

Avicenna Alliance: 
enhanced knowledge, improved decisions, better outcomes